| Name | Title | Contact Details |
|---|
Mirka is the first company in its sector to obtain the three most important quality standards. We strive to guarantee reliable quality by following the ISO 9001 quality assurance system. The OHSAS 18001 occupational health and safety management system
A marketer of bulk food ingredients to the food processing industry, the company was originally founded in 1960 as the G.S. Suppiger Company. In 1986, it began its restructuring into its present form as the LILAR Corporation. It now operates out of a new
Arkansas Baptist Convention is a Camden, AR-based company in the Manufacturing sector.
Oseco is the market leader in manufacturing rupture discs, explosion vents, and other pressure relief products.
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company`s lead product, the VenoValve®, is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). The Company is also developing a non-surgical, transcatheter based replacement venous valve for the treatment of deep venous CVI called enVVe™. CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Both the VenoValve and enVVe are designed to act as one-way valves, to help assist in propelling blood up the leg, and back to the heart and lungs. The VenoValve is currently being evaluated in the SAVVE U.S. pivotal study and the company is currently waiting for regulatory approval to begin the TAVVE first-in-human trial for enVVe.